Sort By:

Men’s HPV Vaccine

The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer. Compensation is available up to $1,150, for those who qualify.

View Trial Details
Ages 20 - 45
Gender For male patients only
Compensation* $1,150
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Pediatrics Meningitis Vaccine

Two month old patients of Legacy Pediatrics may have an opportunity to participate in this study.

View Trial Details
Ages 0 - 1
Study Topics Pediatric, Vaccine